Inventory Summary of Hofseth BioCare ASA

Hofseth BioCare ASA's latest annual inventory in 2023 was 82.54 Million USD , up 594.81% from previous year.
Hofseth BioCare ASA's latest quarterly inventory in 2024 Q2 was 6.77 Million USD , down -13.46% from previous quarter.
Hofseth BioCare ASA reported annual inventory of 11.87 Million NOK in 2022, up 15.5% from previous year.
Hofseth BioCare ASA reported annual inventory of 10.28 Million NOK in 2021, up 20.14% from previous year.
Hofseth BioCare ASA reported quarterly inventory of 7.73 Million USD for 2024 Q1, up 1.42% from previous quarter.
Hofseth BioCare ASA reported quarterly inventory of 10.24 Million USD for 2023 Q2, down -1.27% from previous quarter.

Annual Inventory Chart of Hofseth BioCare ASA (2023 - 2010)

Historical Annual Inventory of Hofseth BioCare ASA (2023 - 2010)

Year	Inventory	Inventory Growth
2023	82.54 Million USD	594.81%
2022	11.87 Million NOK	15.5%
2021	10.28 Million NOK	20.14%
2020	8.56 Million NOK	121.36%
2019	3.86 Million NOK	-86.85%
2018	29.4 Million NOK	74.41%
2017	16.85 Million NOK	8.14%
2016	15.58 Million NOK	-69.32%
2015	50.81 Million NOK	-0.44%
2014	51.04 Million NOK	97.62%
2013	25.82 Million NOK	323.29%
2012	6.1 Million NOK	1339.15%
2011	424 Thousand NOK	0.0%
2010	- NOK	0.0%

Year	Inventory	Inventory Growth
2024 Q2	6.77 Million USD	-13.46%
2024 Q1	7.73 Million USD	1.42%
2023 Q2	10.24 Million USD	-1.27%
2023 Q3	9.48 Million USD	-7.42%
2023 Q4	8.1 Million USD	-14.59%
2023 Q1	10.38 Million USD	-12.62%
2023 FY	82.54 Million USD	594.81%
2022 Q4	11.87 Million NOK	18.75%
2022 Q1	10.52 Million NOK	2.33%
2022 Q2	10.27 Million NOK	-2.34%
2022 Q3	10 Million NOK	-2.68%
2022 FY	11.87 Million NOK	15.5%
2021 Q1	9.99 Million NOK	-86.37%
2021 FY	10.28 Million NOK	20.14%
2021 Q2	10.13 Million NOK	1.47%
2021 Q4	10.28 Million NOK	1.2%
2021 Q3	10.16 Million NOK	0.25%
2020 FY	8.56 Million NOK	121.36%
2020 Q1	45.65 Million NOK	34.33%
2020 Q2	54.88 Million NOK	20.21%
2020 Q3	64.47 Million NOK	17.48%
2020 Q4	73.3 Million NOK	13.68%
2019 Q4	33.98 Million NOK	6.25%
2019 Q1	35.84 Million NOK	21.93%
2019 Q2	42.47 Million NOK	18.49%
2019 FY	3.86 Million NOK	-86.85%
2019 Q3	31.98 Million NOK	-24.7%
2018 Q3	24.4 Million NOK	2.74%
2018 Q2	23.75 Million NOK	15.42%
2018 Q1	20.57 Million NOK	22.07%
2018 FY	29.4 Million NOK	74.41%
2018 Q4	29.4 Million NOK	20.48%
2017 Q4	16.85 Million NOK	-14.74%
2017 Q3	19.77 Million NOK	-26.97%
2017 Q2	27.07 Million NOK	37.5%
2017 FY	16.85 Million NOK	8.14%
2017 Q1	19.69 Million NOK	26.31%
2016 Q4	15.58 Million NOK	-14.68%
2016 FY	15.58 Million NOK	-69.32%
2016 Q3	18.27 Million NOK	-38.61%
2016 Q2	29.76 Million NOK	-35.05%
2016 Q1	45.82 Million NOK	-9.83%
2015 Q2	48.31 Million NOK	-1.12%
2015 FY	50.81 Million NOK	-0.44%
2015 Q3	58.93 Million NOK	21.99%
2015 Q1	48.85 Million NOK	-4.28%
2015 Q4	50.81 Million NOK	-13.77%
2014 Q1	36.62 Million NOK	41.78%
2014 FY	51.04 Million NOK	97.62%
2014 Q4	51.04 Million NOK	-15.3%
2014 Q2	47.8 Million NOK	30.53%
2014 Q3	60.26 Million NOK	26.08%
2013 Q4	25.82 Million NOK	16.2%
2013 Q3	22.22 Million NOK	33.19%
2013 FY	25.82 Million NOK	323.29%
2013 Q2	16.69 Million NOK	156.53%
2013 Q1	6.5 Million NOK	6.62%
2012 Q1	381 Thousand NOK	-10.14%
2012 FY	6.1 Million NOK	1339.15%
2012 Q2	3.85 Million NOK	910.5%
2012 Q4	6.1 Million NOK	157.14%
2012 Q3	2.37 Million NOK	-38.36%
2011 FY	424 Thousand NOK	0.0%
2011 Q3	- NOK	0.0%
2011 Q4	424 Thousand NOK	0.0%
2010 FY	- NOK	0.0%
2010 Q4	- NOK	0.0%

Peer Inventory Comparison of Hofseth BioCare ASA

Name	Inventory	Inventory Difference
Eiger BioPharmaceuticals, Inc.	1.55 Million USD	-5204.756%
Nanobac Pharmaceuticals, Incorporated	10.3 Thousand USD	-801045.297%
SQZ Biotechnologies Company	- USD	-Infinity%
Evofem Biosciences, Inc.	1.69 Million USD	-4763.995%
Santhera Pharmaceuticals Holding AG	2.15 Million USD	-3737.383%
Mesoblast Limited	1.00 USD	-8254199900.0%
Propanc Biopharma, Inc.	- USD	-Infinity%
Genus plc	89.4 Million USD	7.671%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	-94.61 Thousand USD	87342.633%
Marizyme, Inc.	24.85 Thousand USD	-331994.146%
ContraFect Corporation	- USD	-Infinity%
Nymox Pharmaceutical Corporation	16 Thousand USD	-515787.5%
PsyBio Therapeutics Corp.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
RegeneRx Biopharmaceuticals, Inc.	- USD	-Infinity%
Intellipharmaceutics International Inc.	1.00 USD	-8254199900.0%
AXIM Biotechnologies, Inc.	- USD	-Infinity%
MultiCell Technologies, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	784 Thousand USD	-10428.316%
EV Biologics, Inc.	- USD	-Infinity%
Q BioMed Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	1.71 Million USD	-4724.196%
Neon Bloom, Inc.	7938.00 USD	-1039733.711%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
Biomind Labs Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Pharming Group N.V.	56.76 Million USD	-45.423%
Oncotelic Therapeutics, Inc.	- USD	-Infinity%
Skye Bioscience, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	22.57 Thousand USD	-365550.749%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Arch Therapeutics, Inc.	1.36 Million USD	-5949.231%
IMV Inc.	2.00 USD	-4127099900.0%
Acro Biomedical Co., Ltd.	12 Thousand USD	-687750.0%
Curative Biotechnology, Inc.	-115.62 Thousand USD	71487.676%
GB Sciences, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	90.41 Thousand USD	-91194.394%
HST Global, Inc.	- USD	-Infinity%
CSL Limited	5.96 Billion USD	98.616%
Halberd Corporation	- USD	-Infinity%
Enzolytics Inc.	- USD	-Infinity%
Resverlogix Corp.	2.37 Million USD	-3381.316%
Affymax, Inc.	- USD	-Infinity%
SYBLEU INC	- USD	-Infinity%
Nuo Therapeutics, Inc.	209.58 Thousand USD	-39282.792%
argenx SE	310.55 Million USD	73.421%
MetaStat, Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	- USD	-Infinity%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
GeneThera, Inc.	- USD	-Infinity%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
AVAX Technologies, Inc.	11.52 Thousand USD	-716410.417%
Zenith Capital Corp.	3.00 USD	-2751399900.0%
Genscript Biotech Corporation	53.33 Million USD	-54.772%
Ember Therapeutics, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	50 Thousand USD	-164984.0%
WPD Pharmaceuticals Inc.	0.25 USD	-33016799900.0%
American Oriental Bioengineering, Inc.	20.57 Million USD	-301.257%
Provectus Biopharmaceuticals, Inc.	- USD	-Infinity%
Adynxx, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Capstone Therapeutics Corp.	12.83 Million USD	-542.951%
Cotinga Pharmaceuticals Inc.	0.98 USD	-8422652961.224%
BioStem Technologies, Inc.	658.67 Thousand USD	-12431.465%
ONE Bio Corp.	4.5 Million USD	-1732.147%
Reve Technologies, Inc.	- USD	-Infinity%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	1.00 USD	-8254199900.0%
Agentix Corp.	- USD	-Infinity%
LadRx Corporation	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Rasna Therapeutics, Inc.	-20.67 Thousand USD	399413.047%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	-8.71 USD	947669445.58%
Qrons Inc.	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	- USD	-Infinity%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
Nascent Biotech, Inc.	- USD	-Infinity%
Rebus Holdings, Inc.	- USD	-Infinity%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
International Stem Cell Corporation	1.26 Million USD	-6435.392%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	15 Million USD	-450.28%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	- USD	-Infinity%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	- USD	-Infinity%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	- USD	-Infinity%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	1.00 USD	-8254199900.0%
IntelGenx Technologies Corp.	71 Thousand USD	-116156.338%
Gelesis Holdings, Inc.	6.86 Million USD	-1102.36%
CSL Limited	5.96 Billion USD	98.616%
Cellectis S.A.	1.00 USD	-8254199900.0%

Global Stocks Search

Hofseth BioCare ASA (HOFBF)

Inventory Summary of Hofseth BioCare ASA

Annual Inventory Chart of Hofseth BioCare ASA (2023 - 2010)

Historical Annual Inventory of Hofseth BioCare ASA (2023 - 2010)

Peer Inventory Comparison of Hofseth BioCare ASA